Therapeutic Solutions (PK) Stock Price

0.0002 (1.11%)
Volume 5,705,049
Bid Price 0.017
Ask Price 0.0188
News -
Day High 0.0184


52 Week Range


Day Low 0.0169
Company Name Stock Ticker Symbol Market Type
Therapeutic Solutions International Inc (PK) TSOI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0002 1.11% 0.0182 16:28:21
Open Price Low Price High Price Close Price Prev Close
0.0184 0.0169 0.0184 0.0182 0.018
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
77 5,705,049 $ 0.017829 $ 101,713 - 0.01 - 0.1345
Last Trade Time Type Quantity Stock Price Currency
15:24:36 653,475 $ 0.0182 USD


Draw Mode:

Therapeutic Solutions International Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 46.61M 2.56B 303.59M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
19.59k $ - - - -

more financials information »

Therapeutic Solutions (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TSOI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01690.01890.016850.01777631,482,9720.00137.69%
1 Month0.020650.0230.016850.01887662,826,435-0.00245-11.86%
3 Months0.02150.0250.016850.02068422,767,348-0.0033-15.35%
6 Months0.02110.037190.01680.0237343,749,287-0.0029-13.74%
1 Year0.07050.13450.010.0478916,548,898-0.0523-74.18%
3 Years0.003050.1729250.00070.028085510,804,1690.01515496.72%
5 Years0.00530.1729250.00070.02542117,750,4900.0129243.4%

Therapeutic Solutions (PK) Description

Therapeutic Solutions International, Inc. is involved in the medical sciences market. We are focused on three different areas within the same market. They are outlined as follows: 1. Dietary Supplements 2. Immunotherapy Our business plan is twofold: 1. Produce and refine current product lines and develop them further, and 2. To focus on leveraging immunological processes to diagnose and intervene in niche areas of unmet medical needs.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now